Search research articles
Contact Us
Filters
Showing results (21-30 of 40) with videos related to
Page
of 4
Sort By:
Annals of Hematology
|
September 2, 2020
Ruxolitinib treatment improves muscle mass in patients with myelofibrosis
Marko Lucijanic, Davor Galusic, Ena Soric, et al.
Leukemia & Lymphoma
|
March 11, 2017
Heat shock protein 27 (HSP27/HSPB1) expression is increased in patients with primary and secondary myelofibrosis and may be affecting their survival
Marko Lucijanic, Ana Livun, Katarina Marija Tupek, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
July 7, 2016
Canonical Wnt/β-Catenin Signaling Pathway Is Dysregulated in Patients With Primary and Secondary Myelofibrosis
Marko Lucijanic, Ana Livun, Cedna Tomasovic-Loncaric, et al.
Cancer Biology & Therapy
|
September 18, 2007
Bone marrow renin-angiotensin system expression in polycythemia vera and essential thrombocythemia depends on JAK2 mutational status
Maruska Marusic Vrsalovic, Vlatko Pejsa, Tajana Stoos Veic, et al.
Blood Cells, Molecules & Diseases
|
June 13, 2018
Combining information on C reactive protein and serum albumin into the Glasgow Prognostic Score strongly discriminates survival of myelofibrosis patients
Marko Lucijanic, David Cicic, Tajana Stoos-Veic, et al.
Wiener Klinische Wochenschrift
|
November 13, 2019
Neutral effect of Glioma-associated oncogene-1 expression on survival in myelofibrosis
Marko Lucijanic, Ana Livun, Katarina Marija Tupek, et al.
Collegium Antropologicum
|
May 4, 2010
The accuracy of fine needle aspiration cytology and flow cytometry in evaluation of nodal and extranodal sites in patients with suspicion of lymphoma
Petar Senjug, Karmen Trutin Ostović, Zorana Miletić, et al.
Anticancer Research
|
May 2, 2018
Elevated Neutrophil-to-Lymphocyte-ratio and Platelet-to-Lymphocyte Ratio in Myelofibrosis: Inflammatory Biomarkers or Representatives of Myeloproliferation Itself?
Marko Lucijanic, David Cicic, Tajana Stoos-Veic, et al.
Lijecnicki Vjesnik
|
May 16, 2013
[Lymphoma diagnosis and treatment - second Croatian consensus]
Igor Aurer, Slavko Gasparov, Marko Kralik, et al.
Wiener Klinische Wochenschrift
|
January 19, 2021
Higher serum uric acid is associated with higher risks of thrombosis and death in patients with primary myelofibrosis
Marko Lucijanic, Ivan Krecak, Davor Galusic, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 40) with videos related to
Sort By:
Page
of 4
Annals of Hematology
|
September 2, 2020
Ruxolitinib treatment improves muscle mass in patients with myelofibrosis
Marko Lucijanic, Davor Galusic, Ena Soric, et al.
Leukemia & Lymphoma
|
March 11, 2017
Heat shock protein 27 (HSP27/HSPB1) expression is increased in patients with primary and secondary myelofibrosis and may be affecting their survival
Marko Lucijanic, Ana Livun, Katarina Marija Tupek, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
July 7, 2016
Canonical Wnt/β-Catenin Signaling Pathway Is Dysregulated in Patients With Primary and Secondary Myelofibrosis
Marko Lucijanic, Ana Livun, Cedna Tomasovic-Loncaric, et al.
Cancer Biology & Therapy
|
September 18, 2007
Bone marrow renin-angiotensin system expression in polycythemia vera and essential thrombocythemia depends on JAK2 mutational status
Maruska Marusic Vrsalovic, Vlatko Pejsa, Tajana Stoos Veic, et al.
Blood Cells, Molecules & Diseases
|
June 13, 2018
Combining information on C reactive protein and serum albumin into the Glasgow Prognostic Score strongly discriminates survival of myelofibrosis patients
Marko Lucijanic, David Cicic, Tajana Stoos-Veic, et al.
Wiener Klinische Wochenschrift
|
November 13, 2019
Neutral effect of Glioma-associated oncogene-1 expression on survival in myelofibrosis
Marko Lucijanic, Ana Livun, Katarina Marija Tupek, et al.
Collegium Antropologicum
|
May 4, 2010
The accuracy of fine needle aspiration cytology and flow cytometry in evaluation of nodal and extranodal sites in patients with suspicion of lymphoma
Petar Senjug, Karmen Trutin Ostović, Zorana Miletić, et al.
Anticancer Research
|
May 2, 2018
Elevated Neutrophil-to-Lymphocyte-ratio and Platelet-to-Lymphocyte Ratio in Myelofibrosis: Inflammatory Biomarkers or Representatives of Myeloproliferation Itself?
Marko Lucijanic, David Cicic, Tajana Stoos-Veic, et al.
Lijecnicki Vjesnik
|
May 16, 2013
[Lymphoma diagnosis and treatment - second Croatian consensus]
Igor Aurer, Slavko Gasparov, Marko Kralik, et al.
Wiener Klinische Wochenschrift
|
January 19, 2021
Higher serum uric acid is associated with higher risks of thrombosis and death in patients with primary myelofibrosis
Marko Lucijanic, Ivan Krecak, Davor Galusic, et al.
Page
of 4